JPMorgan Downgrades Omnicare (OCR) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- Nasdaq ends sharply lower as hot inflation data stirs rate-hike worries
- Oil prices gain on attacks in Saudi Arabia, Iran's new tactics to target tankers
- U.S. consumer prices rise by 3.7% year-on-year in September
- Bank of America stock falls on earnings miss
- Netflix cuts 1,000 jobs as streaming giant seeks to boost engagement
Tweet
Share
E-mailGet Alerts OCR Hot Sheet
Price: $97.90 --0%
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 10
Rating Summary:
2 Buy, 8 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 6 | New: 10
Join SI Premium – FREE
JPMorgan downgraded Omnicare (NYSE: OCR) from Overweight to Neutral with a price target of $98.00 (from $90.00).
For an analyst ratings summary and ratings history on Omnicare click here. For more ratings news on Omnicare click here.
Shares of Omnicare closed at $95.28 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Baird Downgrades Envista Holdings Corp. (NVST) to Neutral
- Baird Downgrades Align Technology (ALGN) to Neutral
- Wells Fargo (WFC) PT Lowered to $105 at Phillip Securities
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
JPMorganSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
